Apigenin
4' · 5 · 7-trihydroxyflavone · chamomile flavone · 5 · 7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one
Last updated
At a glance
Overview
Why Apigenin Shows Up in So Many Stacks#
Apigenin is a dietary flavone — the active compound behind chamomile tea's calming reputation — that's quietly become one of the more versatile supplements in the longevity, sleep, and estrogen-management toolkit. It hits three distinct mechanisms that matter to physique-focused users: it inhibits CD38 (the enzyme that chews through your NAD⁺), it's a mild aromatase inhibitor, and it modulates the benzodiazepine site of GABA_A for clean sedation without the hangover of Z-drugs or the dependency curve of phenibut.
That mechanistic breadth is why it lands in wildly different protocols. The sleep-stack crowd runs 50 mg pre-bed alongside magnesium and theanine. The longevity crowd runs 500 mg with NMN and resveratrol to protect the NAD⁺ they're paying to raise. On-cycle and cruising users add 50–100 mg as a soft estrogen-trimming adjunct alongside DIM and calcium-D-glucarate. None of these are miracle doses — apigenin is a low-cost multiplier, not a headline compound — but the tolerability is excellent and the downside is minimal.
"Apigenin displayed significant inhibition of CD38 NADase activity in vitro (IC50 ~10 µM) and in cells, resulting in increased intracellular NAD+ levels and protection against diet-induced metabolic dysfunction." — Escande et al., Diabetes (2013)
The rest of this page covers what you actually need to run it well: dose ladders for each use case (sleep, longevity, on-cycle), timing and absorption (why it is dosed with fat and usually at night), stack logic (what pairs with it and what doesn't), realistic expectations vs. a pharma AI or a prescription hypnotic, and the handful of contraindications — pregnancy, hormone-sensitive cancer history, scheduled surgery, warfarin — that matter.
How Apigenin works
CD38 Inhibition and NAD⁺ Preservation#
The headline mechanism for longevity users. CD38 is the dominant NAD⁺-consuming enzyme in mammalian tissue, and it climbs steadily with age — which is a big part of why tissue NAD⁺ falls after 40. Apigenin inhibits CD38 at low micromolar concentrations, and the downstream effect is higher intracellular NAD⁺, which feeds SIRT1 and SIRT3 and keeps mitochondrial oxidative phosphorylation humming. This is why apigenin is stacked with NMN or NR rather than against them — precursors raise the raw material, apigenin stops it being burned through.
"Apigenin displayed significant inhibition of CD38 NADase activity in vitro (IC50 ~10 µM) and in cells, resulting in increased intracellular NAD+ levels and protection against diet-induced metabolic dysfunction." — Escande C. et al., Diabetes, 2013
Practical outcome: better mitochondrial efficiency, improved glucose handling on a recomp, and a small but real contribution to recovery capacity when stacked with NAD⁺ precursors.
Aromatase (CYP19) Inhibition#
Apigenin binds and inhibits aromatase, the enzyme that converts androstenedione and testosterone into estrone and estradiol. The inhibition is real but mild — nowhere near anastrozole or exemestane territory. For a user on TRT or a light bridge, 50–100 mg/day can shave the edge off rising E2. On a wet blast, it's cosmetic.
"Apigenin was found to inhibit aromatase activity in human placental microsomes, reducing the conversion of androstenedione to estrogen at low micromolar concentrations." — Kellis JT, Vickery LE., Science, 1984
There's a twist: at higher concentrations apigenin also binds ERα and ERβ directly, behaving as a weak phytoestrogen. In men at standard doses the aromatase effect dominates, but this is why high-dose long-term use in women is under-characterized, and why it's a hard pass during pregnancy or active conception attempts.
"At higher concentrations, apigenin demonstrated binding affinity for both ERα and ERβ, suggesting it may act as a phytoestrogen with complex estrogenic/antiestrogenic effects." — Nikolic I. et al., Reprod Biol, 2021
GABA_A Benzodiazepine-Site Modulation#
This is the mechanism driving the Huberman-style pre-bed stack. Apigenin binds the benzodiazepine site on GABA_A receptors and produces a measurable anxiolytic and sedative profile — but without the motor impairment, dependence pattern, or amnestic effects of true benzodiazepines. It's the reason chamomile tea works at all, and the reason a 500 mg dose will knock you flat if dosed in the morning.
"Apigenin exhibited anxiolytic effects in animal models with a pharmacological profile similar to benzodiazepines but without significant motor impairment." — Zanoli P, Avallone R, Baraldi M., Fitoterapia, 2000
Practical outcome: smoother sleep onset, subjectively deeper sleep, and better recovery via sleep architecture — the mechanism that actually earns apigenin its spot in most users' stacks.
Pharmacokinetic Reality — Why Dose and Timing Matter#
Oral apigenin sits around 30% bioavailability, with plasma Tmax near two hours and a short plasma half-life (~2.5 h). If that were the whole story it would need multi-daily dosing. It doesn't, because apigenin accumulates in tissue compartments and releases slowly — the tissue half-life stretches the functional duration well past what plasma curves suggest.
"Oral bioavailability of pure apigenin in humans is approximately 30%, with plasma Tmax around 2 hours and a rapid terminal phase, but it accumulates in tissues with a prolonged elimination half-life." — DeRango-Adem EF, Blay J., Front Pharmacol, 2021
Two practical consequences: once-daily dosing is adequate, and absorption is the limiting factor — dry-swallowing capsules on an empty stomach wastes most of the dose. Dose with a fatty meal or in a phospholipid/liposomal carrier.
Anti-Inflammatory and Antioxidant Signalling#
Secondary but worth mentioning. Apigenin suppresses NF-κB signalling, downregulates COX-2 and iNOS expression, and scavenges reactive oxygen species directly. This is the mechanistic basis for the anti-inflammatory reports users describe on longer runs — less joint noise, better recovery between sessions — and likely synergises with the NAD⁺/SIRT3 axis, since SIRT3 activation independently tamps down mitochondrial ROS. Not a reason to run apigenin by itself, but a meaningful contributor to the "feel" at 250–500 mg daily that you don't get from the sleep dose alone.
Protocol
| Level | Dose | Frequency | Notes |
|---|---|---|---|
| Low | 50–100 mg | Once daily | Documented entry-level range |
| Mid | 100–250 mg | Once daily | Most commonly studied range |
| High | 250–500 mg | Once daily | Pre-bed is the default — the GABA_A benzodiazepine-site activity is real and sedation at 250–500 mg will crush a morning session. Take with a fatty meal or phospholipid carrier for absorption. |
Cycle length & outcomes
Documented cycle
4–52 weeks
Plateau after
52 wks
Cycle Length & Protocol#
Apigenin is a flavonoid supplement, not a hormonal compound — there's no HPTA suppression, no receptor downregulation, and no clinical rationale for cycling off. Most users run it continuously once they've picked a lane. The "cycle" framing really just means matching dose and duration to goal.
| Goal | Cycle Length | Daily Dose | Timing |
|---|---|---|---|
| Sleep quality / anxiolysis | Continuous (8+ weeks to judge) | 50 mg | 30–60 min pre-bed |
| On-cycle soft-AI adjunct | Length of cycle + 2 weeks into PCT | 50–100 mg | Pre-bed, with fatty meal |
| NAD⁺ / longevity stack | Continuous (12+ weeks) | 500 mg | Pre-bed, with NMN + TMG |
| Post-cycle estrogen trim | 4–6 weeks bridging into PCT | 100 mg | Pre-bed |
| Hair-stack adjunct | Continuous | 50 mg | Any time with food |
Onset Timing#
Sleep effects are immediate — the GABA_A benzodiazepine-site activity is pharmacological, not adaptive, so the first dose works. If 50 mg pre-bed doesn't noticeably improve sleep onset within 3–5 nights, it's unlikely to.
"Apigenin exhibited anxiolytic effects in animal models with a pharmacological profile similar to benzodiazepines but without significant motor impairment." — Zanoli et al., Fitoterapia (2000)
Aromatase inhibition is gradual. Expect 2–4 weeks of daily dosing before estrogen trimming shows on bloodwork. It's a weak in-vivo AI — useful as a nudge, not a lever.
"Apigenin was found to inhibit aromatase activity in human placental microsomes, reducing the conversion of androstenedione to estrogen at low micromolar concentrations." — Kellis & Vickery, Science (1984)
NAD⁺ / CD38 effects are the slowest to judge. CD38 inhibition raises intracellular NAD⁺ on a timeline of weeks, and the downstream SIRT-driven mitochondrial changes are the kind of thing you notice in training recovery and subjective energy over 8–12 weeks, not overnight.
"Apigenin displayed significant inhibition of CD38 NADase activity in vitro (IC50 ~10 µM) and in cells, resulting in increased intracellular NAD+ levels and protection against diet-induced metabolic dysfunction." — Escande et al., Diabetes (2013)
Loading, Tapering & Absorption#
No loading phase. Tissue accumulation handles that for you — despite the ~2.5 h plasma half-life, apigenin accumulates in tissue with a much slower elimination phase, which is why once-daily dosing is adequate.
"Oral bioavailability of pure apigenin in humans is approximately 30%, with plasma Tmax around 2 hours and a rapid terminal phase, but it accumulates in tissues with a prolonged elimination half-life." — DeRango-Adem & Blay, Front Pharmacol (2021)
No taper on discontinuation. No rebound anxiety, no sleep rebound, no estrogen spike from stopping — it's not a benzodiazepine despite binding the same site, and it's not a pharma AI. Just stop.
Absorption matters more than dose. 30% oral bioavailability is the ceiling; dry-swallowing capsules on an empty stomach puts you well below that. Dose with a fatty meal or use a phospholipid/liposomal formulation. This single tweak is worth more than doubling the dose.
Bloodwork Cadence#
Apigenin itself doesn't require monitoring — no hepatotoxicity, no lipid signal, no kidney impact at community doses. If you're running it as part of an on-cycle estrogen-management stack, standard on-cycle labs apply: sensitive E2, total and free testosterone, lipid panel, LFTs, and CBC every 8–12 weeks. The question bloodwork answers isn't "is apigenin safe" — it's "is my estrogen control actually working," and apigenin at 50–100 mg is rarely the decisive variable there.
Duration Ceiling#
Human safety data past 12 months at 500 mg is thin. The longevity crowd runs it indefinitely and tolerability is anecdotally excellent, but if you want to stay inside the evidence base, 12-week blocks with a 2-week washout once or twice a year is a defensible conservative pattern. At 50 mg for sleep, continuous use is fine.
Confident summary: pick the dose that matches the goal, dose at night with food, give it 2–4 weeks for the subtle mechanisms to show up, and don't expect it to replace a pharma tool it was never built to be.
Risks & mistakes
Common (most users)#
- Drowsiness / morning grogginess — the GABA_A benzodiazepine-site activity is real, especially at 250–500 mg. Dose pre-bed, not AM. If you're still foggy on waking, drop to 100–250 mg or move the dose earlier in the evening.
- Mild GI upset — occasional nausea or loose stools, usually from dry-swallowing capsules on an empty stomach. Dose with a fatty meal or a phospholipid/liposomal formulation; this also meaningfully improves absorption given oral bioavailability sits around 30%.
- Vivid dreams — reported in the sleep-stack crowd, particularly when combined with magnesium glycinate and theanine. Benign; most users consider it a feature.
- Mild sedation at the longevity dose — 500 mg hits harder than people expect. Avoid dosing before training or driving.
"Apigenin exhibited anxiolytic effects in animal models with a pharmacological profile similar to benzodiazepines but without significant motor impairment." — Zanoli et al., Fitoterapia (2000)
Uncommon (dose-dependent or individual)#
- Additive sedation with alcohol, benzodiazepines, phenibut, Z-drugs, DSIP, or high-dose magnesium. Don't stack sedatives — drop the apigenin on nights you're using something else hypnotic.
- CYP-mediated drug interactions — apigenin inhibits CYP3A4, CYP2C9, and CYP1A2 in vitro. Mechanistically relevant for oral AAS (anavar, winstrol), warfarin, and anything with a narrow therapeutic window cleared by these enzymes. Effect at supplement doses is likely modest but not zero; space dosing from orals if you're being cautious.
- Platelet aggregation inhibition — mild, in-vitro. Matters if you're already on fish oil, aspirin, or an anticoagulant, or heading into a surgery / dental procedure. Stop 1–2 weeks before any planned surgery.
- Estrogenic/antiestrogenic ambiguity at high doses — aromatase inhibition dominates at physiologic exposures, but apigenin binds ERα and ERβ at higher concentrations. Practically irrelevant at ≤100 mg in men; at 500 mg long-term the net hormonal effect in humans is under-characterized.
"At higher concentrations, apigenin demonstrated binding affinity for both ERα and ERβ, suggesting it may act as a phytoestrogen with complex estrogenic/antiestrogenic effects." — Nikolic et al., Reprod Biol (2021)
Rare but serious#
- Allergic reaction — apigenin is a chamomile/parsley-family flavone. Anyone with a documented ragweed, chamomile, or Asteraceae allergy should skip it. Hives, throat tightness, or swelling = stop immediately.
- Bleeding episodes on concurrent anticoagulants — unexplained bruising, nosebleeds, or heavier-than-normal cuts while on warfarin or high-dose antiplatelet regimens warrant stopping and rechecking INR.
There are no documented cases of hepatotoxicity, nephrotoxicity, or cardiac events at community doses in the human literature. The safety profile is genuinely clean.
Hard contraindications#
- Pregnancy and trying to conceive — animal data show adverse effects on implantation and fetal development at high doses. Do not use.
- Hormone-sensitive cancer history (ER+ breast cancer, endometrial cancer) — the ER-binding activity at high concentrations is not something to self-prescribe around. This is an oncologist conversation, not a supplement-stack one.
- Warfarin use — the combined CYP2C9 inhibition and antiplatelet activity is a real interaction. Don't add apigenin to warfarin without explicit anticoagulation management.
- Scheduled surgery — stop at least 1–2 weeks prior.
- Concurrent benzodiazepines, Z-drugs, or other GABAergic hypnotics — additive CNS depression. Pick one.
Gender-specific and PCT considerations#
Apigenin does not suppress the HPTA, does not require PCT, and can be run continuously on- or off-cycle. Women tolerate 50–100 mg/day without issue — this is the dose range backed by human tolerability data. The 500 mg longevity dose in women is under-characterized given apigenin's ER-binding profile at high concentrations; keep female dosing conservative and avoid entirely during pregnancy or active conception attempts. For men running it as a "soft AI" on a mild cycle or cruise, set expectations appropriately: 50–100 mg will nudge estrogen, not control it on a wet blast — that's still a pharma AI's job.
Stack & combine
Featured in stacks1 curated protocol include Apigenin
FAQ — Apigenin
Research & citations
5 studies cited on this page.
Conclusion
Apigenin is a highly underrated tool for sleep quality, NAD⁺ optimization, and modest estrogen management — not a miracle compound, but a reliable addition when slotted smartly into your stack.
Key takeaways:
- Standard dose: 50–100 mg daily for sleep, mild estrogen trimming, or general health; 500 mg for longevity/NAD⁺ stacks
- Always take with a fatty meal or phospholipid carrier to maximize absorption (bioavailability ≈30%)
- Run pre-bed for the best sleep/anxiolytic benefit — 500 mg will sedate most users
- Stacks synergistically with magnesium, theanine, NMN/NR (in longevity setups), and DIM/calcium D-glucarate for mild estrogen support
- Well-tolerated, but avoid if pregnant, trying to conceive, or with hormone-sensitive cancer history
- Do not expect pharma-grade estrogen control; this is a soft, supportive adjunct, not a replacement for AIs
Whether you're chasing deeper sleep, smoother estrogen management on a cruise, or plugging a CD38-shaped hole in your longevity stack, apigenin is low-risk, inexpensive, and effective within its lane.